According to an analysis of the Life Span Study cohort data conducted by the Radiation Effects Research Foundation in Hiroshima and Nagasaki, the sex-averaged excess relative risk (ERR) of all solid cancers was 0.42 Gy-Eq −1 . On the other hand, analysis of the atomic bomb survivors (ABS) cohort data at Hiroshima University indicated the ERR value was 0.28 Gy-Eq −1 in Hiroshima. In both cases, initial radiation doses were derived from the dosimetry system DS02, in which the relative biological effectiveness (RBE) of neutrons was assumed to be a constant value of 10. To clarify the validity of the RBE, the authors investigated the possibility of different contributions of neutrons by using the ABS. Although there were no statistically significant differences among the estimated value of RBE (=65) and the ordinal value (=10), the corresponding ERR decreased by 30%, which might affect the interpretation of radiation health assessments.
INTRODUCTION
There are three large cohort studies on radiation health risks among the atomic bomb survivors in Japan. These studies have been conducted mainly by three independent bodies: Radiation Effects Research Foundation (RERF), Research Institute of Radiation Biology Medicine (RIRBM) of Hiroshima University and Nagasaki University. According to the results of the Life Span Study (LSS) conducted by RERF from 1950 to 2003 in Hiroshima and Nagasaki (1) , the sexaveraged excess relative risk (ERR) of all solid cancers was 0.42 Gy-Eq −1 for the subjects with an attained age of 70 years who were exposed at the age of 30. Whereas, RIRBM reported that the ERR for all solid cancers was 0.28 Gy-Eq −1 for the atomic bomb survivors in Hiroshima during the period from 1970 to 2010 (2) . In both cases, initial radiation doses were calculated based on the dosimetry system DS02 (3, 4) , in which the relative biological effectiveness (RBE) of neutrons was assumed to be a constant value of 10. To clarify the validity of the RBE, the authors investigated the possibility of different contributions of neutrons by using the cohort data from RIRBM.
MATERIALS AND METHODS
For the present study, the authors used the atomic bomb survivors (ABS) database that has been managed by RIRBM of Hiroshima University (5) . Unlike the LSS of RERF, which is based on subjects throughout Japan, the ABS is restricted to atomic bomb survivors residing in Hiroshima Prefecture. For analysis, the authors chose 13 922 subjects (4929 men and 8993 women) from the ABS who satisfied the following conditions: (1) Certified as an atomic bomb survivor by Hiroshima City Hall as of 1 January 1970. (2) Alive on 1 January 1970, which is the start of the observation period. (3) Having accurate information available on the coordinates of their location at the time of atomic bomb exposure, with an accuracy of <100 m on the map. These subjects were followed until 31 December 2010. The endpoint is death from solid cancers (number of deaths: 858 men and 1176 women). Subjects were considered alive at the end of follow-up or were censored if they moved outside the study area or were lost to follow-up (number of subjects: 4071 men and 7817 women).
Radiation dosimetry
To assess the effect of initial radiation dose on the human body, the authors used the colon absorbed neutron and gamma ray doses (unit of measurement: Gy) multiplied by RBEs of the radiation components estimated using the Atomic Bomb Survivor 2016 Dose, which is referred to as ABS16D (2) and is based on the dosimetry system DS02 (3, 4) . Initial doses based on DS02 can be derived from the following covariates: (1) distance from the hypocentre, (2) sex, (3) age at atomic bomb exposure and (4) shielding condition. Estimations of radiation doses in the ABS were also discussed (5, 6) . Figure 1 shows the distance distribution of atomic bomb survivors. Since the authors removed the records without sufficient accuracy to specify the location at exposure, there were fewer survivors over 2000 m from the hypocentre.
The extent of overlap between survivors in the ABS and the LSS was examined (6, 7) . The number of survivors according to distance from the hypocentre adapted from the frequency table in Hayakawa et al. (7) is shown in Table 1 . Mesh coordinates of 100 m in width or exact points from a geographic information system were used to determine the location at exposure (6) . The Cohen's kappa correlation coefficient, which can be used to find the agreement of two rates, was 0.77. This implies that there are no significant differences in distances between the ABS and LSS.
Hayakawa et al. (7) also concluded that the dose estimates of the ABS were close to those of the LSS among the subjects that overlapped. RERF has published the grouped data that was based on DS02 and explained by Preston et al. (8) . Colon doses from the ABS are compared to rectal doses from the LSS in Figure 2 . As shielded kerma estimates are truncated to 4 Gy in the LSS, the grouped means around 500 m are smaller than those from the ABS. Since shielding effects are more often considered in the LSS than the ABS, doses from the LSS are smaller than those from the ABS for almost all ranges. On the other hand, maximum values at the same distance were similar.
Kaplan-Meier curves
In this work, the Kaplan-Meier method was used to confirm the survival time of atomic bomb survivors and the dependency of survival time on the initial radiation dose (Figure 3 ). The censoring information is shown in Table 2 . Figure 3 shows the survival rate for the dose-specific strata. For these strata, the authors compared the survival curves of the cohorts exposed to the dose categories listed in Table 2 . The survival rates for higher dose groups [1, 1.5], [1.5, 2] and [2, 6] are much smaller than the other groups. 
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Statistical model
The ERR model (1) was constructed for all cohort data with zero or positive dose at exposure, according to the linear no-threshold (LNT) hypothesis, which can be described with the hazard function:
where t is the attained age and h 0 (t) is a baseline hazard function for a control group with zero dose at exposure. The ERR was calculated as follows:
where RBEn is the relative biological effectiveness of neutrons, and Dg and Dn are the colon absorbed dose of gamma rays and neutrons, respectively. Em is the effect modifier term, which is specified as follows: where A is the age at exposure and S is a flag (−1 or 1) that indicates sex. In the analysis, RBEn was assumed to be an unknown or given parameter. The regression coefficients (b 1 , b 2 and b 3 ) were estimated by minimization of minus two times log-likelihood using the ABS. The authors used the 'survival' package for survival analysis to deal with censored data and 'gnm' package for generalized nonlinear models including the ERR model in R (9) . Especially, b 0 is a regression coefficient of the initial radiation dose and can be interpreted as the sex-averaged ERR per dose for the subjects at the attained age of 70 who were exposed at the age of 30. Note that the recent result of the LSS was reported by considering the effects of smoking in the frame of a more complex model (10) .
RESULTS AND DISCUSSION
An ordinal statistical strategy cannot be applied to the survivors' data for estimation of neutrons' RBE because of the high correlation between the neutron doses and gamma ray doses. This is known as a multicollinearity problem (11) . Thus, the authors attempted to evaluate the log-likelihood at several RBE values in the range of 5-120 including the ordinal constant value of RBE = 10. The authors also estimated the RBE for the published LSS cohort data (8) , which contained rectal gamma ray and neutron data, separately.
As a result, although there were no statistically significant differences among the minus two times log-likelihood values, the authors found that the condition of RBE = 65 achieved the minimum value; it is six times higher than the ordinal value (=10) that has been commonly used in past analyses (Figure 4) . The RBE for the published LSS cohort data was also estimated to be 75 by the authors; it was close to the value of 65 for the ABS, but was also not significantly different.
Two values of RBE can be statistically different when the difference in the deviances is >3.84, which is the upper 5% point of the Chi-squared distribution with 1 degree of freedom. Kellerer et al. (12) derived similar results, showing that the RBE was estimated to be 100 with a 95% confidence lower limit of 25 based on the LSS. Cullings et al. (11) pointed out that the RBE could change according to dose level. Ruhm and Walsh (13) reported RBE = 40.2 at 500 m and RBE = 25.1 at 2000 m according to the International Commission on Radiological Protection Report 60 Figure 3 . Comparison of survival rates of which the endpoint is death from solid cancer at different dose ranges (Gy Eq). Table 2 . Number of censored and death cases by dose (also shown as survival curves in Figure 3 ). recommendation. These values are at least twice as large as RBE = 10. Thus, the change in RBE using the ERR model may affect the interpretation of radiation health assessments. Figure 5 shows the estimated regression coefficient b 0 ; the resultant ERR per dose changes dramatically. Since the mortality rate is fixed, the regression coefficient b 0 decreases as RBEn increases in equation (2) . Thus, the ERR per dose decreases by 30% when RBE increases to 65 from the ordinal value of 10.
As a result of the dosimetry revision from DS86 to DS02, Preston et al. (8) reported that the estimates of solid-cancer radiation risk per dose were decreased by~8% due to the increase in the gamma-ray dose estimates. Satoh et al. (2) found that the ERR per dose decreased by~7% in the ABS. Therefore, a 30% reduction in the ERR per dose due to the change in RBE can have a comparatively large impact on radiation health assessments. . Difference in deviances given by minus two times log of the likelihood ratio between the RBE and the RBE at the minimum for the ABS and published LSS grouped data (8) . Under the null hypothesis that optimized RBE = 10, the p-values for the ABS and LSS were 0.408 and 0.226, respectively. (2), or the sex-averaged excess relative risk per dose of all solid cancers for the subjects aged at least 70 years who were exposed at the age of 30.
